Armağan, B. Et Al. 2023. COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.. International journal of rheumatic diseases , vol.26, no.5 , 930-937.

Armağan, B., Konak, H. E., Özdemir, B., Apaydın, H., Atalar, E., Akyüz Dağlı, P., ... Güven, S. C.(2023). COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.. International journal of rheumatic diseases , vol.26, no.5, 930-937.

Armağan, Berkan Et Al. "COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.," International journal of rheumatic diseases , vol.26, no.5, 930-937, 2023

Armağan, Berkan Et Al. "COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.." International journal of rheumatic diseases , vol.26, no.5, pp.930-937, 2023

Armağan, B. Et Al. (2023) . "COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.." International journal of rheumatic diseases , vol.26, no.5, pp.930-937.

@article{article, author={Berkan Armağan Et Al. }, title={COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.}, journal={International journal of rheumatic diseases}, year=2023, pages={930-937} }